RIG
GSK icon

Roosevelt Investment Group’s GSK GSK Stock Holding History

Roosevelt Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$313K Sell
10,628
-1,477
-12% -$56K 0.02% 220
2022
Q2 		$659K Buy
12,105
+163
+1% +$9K 0.05% 158
2022
Q1 		$650K Buy
11,942
+1,025
+9% +$55.7K 0.04% 174
2021
Q4 		$602K Buy
+10,917
New +$568K 0.03% 175
2013
Q3 		– Sell
-4,493
Closed -$281K – 272
2013
Q2 		$281K Buy
+4,493
New +$285K 0.01% 230

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Roosevelt Investment Group's GSK Position: Q3 2022 in Review

Roosevelt Investment Group reduced its GSK (GSK) stake by 12% in Q3 2022, selling an estimated $56K and leaving 10,628 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #220.

Roosevelt Investment Group first reported a position in GSK in Q2 2013 and has held it in 5 quarters since. The position peaked at $659K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Roosevelt Investment Group held 10,628 shares of GSK worth $313K as of Q3 2022.
  • Roosevelt Investment Group sold 1,477 GSK shares in Q3 2022, an estimated $56K.
  • GSK made up 0.02% of Roosevelt Investment Group's portfolio in Q3 2022, its #220 holding.
  • Roosevelt Investment Group first reported a position in GSK in Q2 2013 and has held it in 5 quarters since.
  • Roosevelt Investment Group's GSK position peaked at $659K in Q2 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.